McKinley Capital Management’s Bio-Techne TECH Stock Holding History

McKinley Capital Management’s Portfolio TECH Stock Details TECH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-36,220	Closed	-$2.96M	–	170
2023 Q2	$2.96M	Sell	36,220 -4,700	-11%	-$378K	0.4%	79
2023 Q1	$3.04M	Hold	40,920	–	–	0.4%	82
2022 Q4	$3.39M	Hold	40,920	–	–	0.45%	76
2022 Q3	$2.9M	Hold	40,920	–	–	0.39%	86
2022 Q2	$3.55M	Hold	40,920	–	–	0.46%	77
2022 Q1	$4.43M	Hold	40,920	–	–	0.44%	79
2021 Q4	$5.29M	Hold	40,920	–	–	0.47%	71
2021 Q3	$4.96M	Buy	40,920 +9,880	+32%	+$1.2M	0.47%	79
2021 Q2	$3.49M	Hold	31,040	–	–	0.24%	103
2021 Q1	$2.96M	Buy	31,040 +18,080	+140%	+$1.65M	0.22%	107
2020 Q4	$1.03M	Hold	12,960	–	–	0.07%	146
2020 Q3	$803K	Hold	12,960	–	–	0.06%	149
2020 Q2	$856K	Hold	12,960	–	–	0.06%	143
2020 Q1	$614K	Hold	12,960	–	–	0.05%	152
2019 Q4	$711K	Buy	+12,960	New	+$680K	0.05%	164
2019 Q3	–	Sell	-12,960	Closed	-$676K	–	209
2019 Q2	$676K	Buy	+12,960	New	+$653K	0.04%	174

Other funds holding TECH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

DDC

DF Dent & Co Baltimore, Maryland $5.27B AUM 7.89% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

McKinley Capital Management's TECH Position: Q3 2023 in Review

McKinley Capital Management sold out of Bio-Techne (TECH) in Q3 2023, closing a stake of 36,220 shares — an estimated $2.96M sold.

McKinley Capital Management first reported a position in TECH in Q2 2019 and held it in 16 quarters. The position peaked at $5.29M in Q4 2021. 530 funds tracked by Wall St. Rank hold TECH as of Q3 2023.

McKinley Capital Management reported no remaining Bio-Techne position as of Q3 2023 after selling out during the quarter.
McKinley Capital Management sold 36,220 Bio-Techne shares in Q3 2023, an estimated $2.96M.
McKinley Capital Management first reported a position in Bio-Techne in Q2 2019 and held it in 16 quarters.
McKinley Capital Management's Bio-Techne position peaked at $5.29M in Q4 2021.
530 funds tracked by Wall St. Rank held Bio-Techne as of Q3 2023.

Based on McKinley Capital Management's 13F filing for Q3 2023, filed 13 Nov 2023.